Study finds no difference in survival rate for gallbladder cancer patients based on liver resection size

FHS
July 24, 2023
4:10 pm

Gallbladder cancer is most common in people who have gallstones or have had gallstones in the past.

Clinical trial highlights efficacy of imlifidase for kidney transplant recipients

For kidney transplant recipients experiencing antibody-mediated rejection, the current standard of care involves removing donor-specific antibodies (DSAs) through plasmapheresis (PLEX)-;a procedure that removes antibodies from

October 27, 2024

The Metaverse Experiences Benefiting the Aging Population

Bent Philipson, Founder of Philosophy Care Have you ever envisioned a world where age doesn’t restrict exploration? Where do the boundaries of reality dissolve and

March 6, 2024

Epidemic: What good is a vaccine when there is no rice?

The 1970s was the deadliest decade in the “entire history of Bangladesh,” said environmental historian Iftekhar Iqbal

October 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.